Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
daclatasvir (daklinza) (1 trial)
ledipasvir (Harvoni) (1 trial)
l-epigallocatechin (1 trial)
natural anti-hemolytic (1 trial)
ribavirin (virazole) (2 trials)
sofosbuvir (sovaldi) (3 trials)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Virus Diseases (Phase 3)
Trials (3 total)
Trial APIs (6 total)